Interleukin 6 (IL6) has been recognized to be the most important driver of immune dysregulation and ARDS in COVID-19 and a predictive factor for a severe form of the disease (Magro 2020; Giamarellos-Bourboulis et al. 2020; Setyo Nugroho et al. 2022; Zhang et al. 2020; Mandel et al. 2020). The gene discussed is IL6; the disease is acute respiratory distress syndrome.